Literature DB >> 11201226

Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L.

T Murakami1, A Emoto, H Matsuda, M Yoshikawa.   

Abstract

Eight cucurbitane-type triterpene glycosides called goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h and three oleanane-type triterpene saponins termed goyasaponins I, II, and III were isolated from the fresh fruit of Japanese Momordica charantia L. (Cucurbitaceae) together with five known cucurbitane-type triterpene glycosides momordicosides A, C, F1, I, and K. The structures of goyaglycosides and goyasaponins were elucidated on the basis of chemical and physicochemical evidence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11201226     DOI: 10.1248/cpb.49.54

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  17 in total

1.  Cucurbitane-Type Triterpenoids from the Vines of Momordica charantia and Their Anti-inflammatory Activities.

Authors:  Hung-Tse Huang; Li-Jie Zhang; Hui-Chi Huang; Syh-Yuan Hwang; Chia-Lun Wu; Yu-Chi Lin; Chia-Ching Liaw; Yung-Yi Cheng; Susan L Morris-Natschke; Chung-Yi Huang; Kuo-Hsiung Lee; Yao-Haur Kuo
Journal:  J Nat Prod       Date:  2020-05-01       Impact factor: 4.050

2.  The effect of Momordica charantia intake on the estrogen receptors ESRα/ESRβ gene levels and apoptosis on uterine tissue in ovariectomy rats.

Authors:  Ozge Cevik; Hikmet Akpinar; Rabia Oba; Ozlem Tugce Cilingir; Zarife Nigar Ozdemir; Sule Cetinel; Tevfik Yoldemir
Journal:  Mol Biol Rep       Date:  2014-09-25       Impact factor: 2.316

Review 3.  Bitter melon: a panacea for inflammation and cancer.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Subhash B Padhye; Shrikant Anant
Journal:  Chin J Nat Med       Date:  2016-02

4.  Inhibition of nuclear transcription factor-κB and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantia.

Authors:  Nguyen Xuan Nhiem; Pham Hai Yen; Nguyen Thi Thanh Ngan; Tran Hong Quang; Phan Van Kiem; Chau Van Minh; Bui Huu Tai; Nguyen Xuan Cuong; Seok Bean Song; Young Ho Kim
Journal:  J Med Food       Date:  2012-01-16       Impact factor: 2.786

5.  Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine.

Authors:  Shuaizhen Zhou; Pierre-Marie Allard; Christian Wolfrum; Changqiang Ke; Chunping Tang; Yang Ye; Jean-Luc Wolfender
Journal:  Metabolomics       Date:  2019-07-18       Impact factor: 4.290

6.  13, 14-Epoxyoleanan-3-ol-acetate: A Male Fertility-Enhancing Constituent from Hexane Fraction of Momordica charantia L. (Cucurbitaceae).

Authors:  Oluwasegun Adedokun; Adebayo Gbolade; Bunyaminu Ayinde
Journal:  Turk J Pharm Sci       Date:  2022-04-29

Review 7.  Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.

Authors:  Komal Raina; Dileep Kumar; Rajesh Agarwal
Journal:  Semin Cancer Biol       Date:  2016-07-21       Impact factor: 15.707

8.  Allylic hydroxylation of triterpenoids by a plant cytochrome P450 triggers key chemical transformations that produce a variety of bitter compounds.

Authors:  Shohei Takase; Kota Kera; Yoshiki Nagashima; Kazuto Mannen; Tsutomu Hosouchi; Sayaka Shinpo; Moeka Kawashima; Yuki Kotake; Hiroki Yamada; Yusuke Saga; Junnosuke Otaka; Hiroshi Araya; Masaaki Kotera; Hideyuki Suzuki; Tetsuo Kushiro
Journal:  J Biol Chem       Date:  2019-10-27       Impact factor: 5.157

Review 9.  Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome.

Authors:  Md Ashraful Alam; Riaz Uddin; Nusrat Subhan; Md Mahbubur Rahman; Preeti Jain; Hasan Mahmud Reza
Journal:  J Lipids       Date:  2015-01-12

10.  Antioxidant Potential of Momordica Charantia in Ammonium Chloride-Induced Hyperammonemic Rats.

Authors:  A Justin Thenmozhi; P Subramanian
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.